Home / News
-
-
South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's Allplex 2019-nCoV Assay2020-04-22View More
-
-
A new study launched by scientists at Hannover Medical School (MHH) in Germany is determined to find out why patients respond differently to COVID-19.2020-04-22View More
-
-
Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate.2020-04-22View More
-
-
In the months since SARS-CoV-2 emerged and began spreading, researchers have been attempting to collect new data to understand the virus and COVID-19 disease it causes.2020-04-22View More
-
-
Genomic epidemiology papers from two independent teams are exploring potential sources of recent SARS-CoV-2 introductions to China's Guangdong province and to Connecticut, respectively2020-04-22View More
-
-
A new consortium spearheaded by the New York Genome Center aims to foster and organize genomic COVID-19 research in the New York metropolitan area.2020-04-22View More
-
-
A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.2020-04-15View More
-
-
This article has been updated from a previous version to include additional information about the saliva collection device specified in the EUA summary.2020-04-15View More
-
-
Lawmakers on Thursday called on the US Food and Drug Administration to provide information about the accuracy of the various SARS-CoV-2 diagnostics being used in response to the ongoing pandemic.2020-04-15View More
-
-
Prompted in part by the COVID-19 pandemic, the T.H. Chan School of Public Health at Harvard University2020-04-15View More
-
-
African genomics research company 54gene said on Tuesday that it has closed a $15 million Series A financing round.2020-04-15View More
-
-
A multi-omic analysis of high-grade serous ovarian cancer has uncovered molecular differences between clinical subgroups of the disease.2020-04-15View More
-
-
The US Food and Drug Administration on Monday granted Emergency Use Authorization to two lab-developed real-time RT-PCR tests for SARS-CoV-2, the virus that causes coronavirus disease COVID-19.2020-04-15View More
-
-
Illumina reported after the close of the market on Tuesday preliminary first quarter revenues of approximately $858 million. The firm also withdrew its full-year revenue guidance due to disruption from the COVID-19 pandemic.2020-04-15View More
-
-
Fluidigm said after the close of the market on Tuesday that it expects Q1 revenues of approximately $27.6 million.2020-04-15View More
-
-
A new research portal from software developer Nference and Johnson & Johnson's Janssen Pharmaceutica has identified several new expression mechanisms for COVID-19 and the novel SARS-CoV-2 coronavirus that causes the deadly disease.2020-04-15View More
-
-
The National Institutes of Health have started recruiting for a new study that aims to determine how many adults in the US who have not had a confirmed infection with SARS-CoV-2 carry antibodies to the virus, indicating that they were previously infected.2020-04-15View More
-
-
From a purple dot in Wuhan, China, lines start to emerge, reaching the UK, Thailand, and Australia.2020-04-15View More
-
-
LexaGene, which has developed a pathogen detection platform for the veterinary and food safety sectors, is now pivoting to clinical diagnostics by modifying its LX Analyzer platform for viruses2020-04-07View More
-
-
A team led by researchers at St. Jude Children's Research Hospital, the European Molecular Biology Laboratory2020-04-07View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.